Holocene Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $607K | Sell |
3,270
-61,830
| -95% | -$11.5M | ﹤0.01% | 684 |
|
2025
Q1 | $13.6M | Sell |
65,100
-1,042,042
| -94% | -$218M | 0.04% | 259 |
|
2024
Q4 | $197M | Buy |
+1,107,142
| New | +$197M | 0.63% | 39 |
|
2024
Q3 | – | Sell |
-1,195,042
| Closed | -$205M | – | 699 |
|
2024
Q2 | $205M | Sell |
1,195,042
-47,967
| -4% | -$8.23M | 0.86% | 26 |
|
2024
Q1 | $226M | Sell |
1,243,009
-417,484
| -25% | -$76M | 0.83% | 30 |
|
2023
Q4 | $257M | Buy |
+1,660,493
| New | +$257M | 1% | 16 |
|
2022
Q1 | – | Sell |
-1,216,806
| Closed | -$165M | – | 846 |
|
2021
Q4 | $165M | Sell |
1,216,806
-596,047
| -33% | -$80.7M | 0.86% | 22 |
|
2021
Q3 | $196M | Buy |
1,812,853
+729,682
| +67% | +$78.7M | 1.06% | 14 |
|
2021
Q2 | $122M | Buy |
1,083,171
+195,231
| +22% | +$22M | 0.69% | 32 |
|
2021
Q1 | $96.1M | Sell |
887,940
-354,514
| -29% | -$38.4M | 0.6% | 44 |
|
2020
Q4 | $133M | Buy |
1,242,454
+158,628
| +15% | +$17M | 0.84% | 16 |
|
2020
Q3 | $94.9M | Buy |
1,083,826
+466,355
| +76% | +$40.8M | 0.72% | 36 |
|
2020
Q2 | $60.6M | Buy |
+617,471
| New | +$60.6M | 0.53% | 57 |
|